Brickell Biotech, Inc. (BBI)
Current
- (-)
After Hours
Rating Performance
Rating Return
-3.76% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
+0.57% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
-30.61% vs
Rating Accuracy
25.0% (1 of 4*)
Rating Return
-78.55% vs
Rating Accuracy
16.67% (1 of 6*)
FV Performance
FV Accuracy
11 Hits (157.14% Hit Rate)
FV Avg. Distance
-21.76%
FV Accuracy
11 Hits (84.62% Hit Rate)
FV Avg. Distance
-22.91%
FV Accuracy
11 Hits (44.0% Hit Rate)
FV Avg. Distance
+34.14%
FV Accuracy
50 Hits (102.04% Hit Rate)
FV Avg. Distance
+36.23%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Robert B. Brown
Employees
15
Industry
-
Sector
-
Headquarters
Boulder
Exchange
NASDAQ
Website
http://www.brickellbio.comSummary Stats
Market Cap
14.5M
Revenue
479K
Net Income
-39.9M
EPS
-$0.42
Price-to-Earnings
-0.29
Price-to-Book
0.9
Debt-to-Equity
0.3
News
Analyst Ratings
Price targets projected by 2 analysts
High
$6.00
Average
$5.50
Low
$5.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Missed by -$0.02
-$0.08 -33.3%
-0.06
-0.15
Up 46%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--